Airline Wet Wipes: FDA–EPA Claim Boundaries for Cabin Procurement

Key takeaways. A cabin wipe for passengers’ skin is not interchangeable with a chemical surface-disinfection wipe. In the United States, intended use and the words on the wrapper determine whether a disposable wipe is treated as a cosmetic, a drug, or an EPA-regulated surface antimicrobial. Buyers should approve the claim, formula, substrate and evidence together before printing airline-branded packs.

An airline may buy refreshing towels for passengers, cleaning wipes for service equipment and registered disinfectants for specified surfaces. Their packs can look similar, but their claims and evidence cannot simply be copied from one purchase order to another. This distinction matters when a caterer combines products in a cabin-service kit or an airport contractor asks the same supplier for a different use.

What the US regulators actually say

The US Food and Drug Administration’s Disposable Wipes guidance says wipes intended to cleanse or moisturize skin are generally cosmetics. A wipe intended to kill germs on skin or make another therapeutic claim is a drug. A wipe intended to sanitize or disinfect an inanimate surface is under the Environmental Protection Agency’s remit. An object-cleaning wipe without an antimicrobial claim can fall under a different consumer-product regime. The classification is driven by intended use, not by the nonwoven sheet’s appearance.

EPA’s cleaning, sanitizing and disinfecting explanation, updated 8 October 2026, distinguishes soil removal from antimicrobial action on surfaces. A sanitizer claim concerns bacteria; a disinfectant claim concerns bacteria and viruses supported by the registered label. EPA says users must follow that label, including the time a surface remains wet. These are US regulatory distinctions; buyers serving other countries must separately check local requirements. They are not evidence that any XHANCO wipe has an antimicrobial registration or efficacy.

Two XHANCO formats, two specification questions

For a passenger hand-and-face refresh service, the 45 gsm individually wrapped airline wet wipe is a useful specification starting point. Ask whether the intended claim is only gentle cleansing; then agree on the wetting formula, ingredient disclosure, fragrance position, sheet dimensions, pack seal and shelf-life evidence for the destination market. Do not add “kills germs,” “sanitizes hands” or similar wording to the artwork without a separate regulatory assessment and substantiation.

For a more substantial premium-cabin or lounge amenity, the 20 g airline refreshing towel presents different engineering questions: towel mass, folded size, wrap integrity, distribution speed and disposal route. The wrap’s material claim must be evidenced separately from any skin-use claim for the towel. “Biodegradable wrap” is not a substitute for testing the actual finished structure, verifying local end-of-life rules or proving that the whole kit composts.

Neither product example should be represented as a surface disinfectant on the strength of being wet or individually packed. If a buyer needs a surface disinfectant, it should source the appropriate registered product and review its label, permitted surfaces, use dilution if any and contact time. EPA also explains that surface disinfectants should not be used on people.

A claim-to-evidence review before the artwork is locked

1. Define the user and surface. Record whether the item touches intact skin, a tray table, catering equipment or another surface; specify the destination countries and language versions.
2. Freeze one intended-use statement. Compare every front-panel phrase, pictogram, sales sheet and QR landing page with the intended use. A marketing headline can change the regulatory category even when the liquid is unchanged.
3. Request the right formula file. Review ingredients, preservatives, fragrance/allergen disclosures where relevant, supplier identity and change-control rules. Ask what stability and microbial-quality testing supports the proposed storage period.
4. Qualify the physical pack. Test seal strength, liquid retention, leakage after transport simulation, ease of opening with gloves, print legibility and barcode readability using the real master-carton and unit-pack configuration.
5. Test the service scenario. Trial the wipe or towel in the aircraft or catering workflow: one-handed opening, passenger comfort, pack waste, crew distribution time and handling after hot/cold storage.
6. Approve evidence before claims. Obtain destination-specific legal review and any required registration or substantiation before printing antimicrobial, compostability or safety claims. Keep the approved proof, formula revision and acceptance sample traceable to each order.

Current requirements versus future changes

As of 26 October 2026, the FDA and EPA distinctions linked above are current US guidance. This article does not identify a new FDA or EPA phase-in date for ordinary cabin wipes, nor should a future deadline be inferred from an unrelated packaging regulation. Procurement teams should monitor official updates in each destination market and reassess a product when its formula, claim, artwork or use changes. An existing cosmetic-cleansing specification does not automatically authorize a future disinfectant claim.

For an OEM discussion, send XHANCO the intended use, destination, sheet or towel specification, proposed pack text, annual volume and the evidence your compliance team expects. Contact the export team to discuss samples and a claim-neutral quotation; any regulatory claim should remain subject to buyer review and supporting documents.

Sources: US FDA, Disposable Wipes; US EPA, Disinfect, Sanitize and Clean (updated 8 October 2026); US EPA, Disinfectants and People. Cover photograph: Towfiqu barbhuiya / Pexels, free for commercial website use under the Pexels License; cropped from the source photograph to 1200 × 675 px. Editorial image only; it does not depict a XHANCO product or imply efficacy.